Main Menu

Coronavirus (COVID-19)

Coronavirus updates

Last updated 25 March, 9:15 pm

This page will collect together the latest information about The Institute of Cancer Research's response to coronavirus (COVID-19) as relates to our staff and students, as well as to visitors, fundraisers, and other external stakeholders.

We are following the latest advice for the UK from the Department of Health and Social Care and Public Health England and ICR staff and students should use the official Government response page for the latest information.

ICR staff are now working from home in line with Government guidelines. This will likely create additional delays for many enquiries. Please bear with us as we transition to new working arrangements. 

News updates

Impact on research

All ICR laboratories in Chelsea and the majority of those in Sutton have now closed. Only very small numbers of people in essential research or maintenance roles remain on site. Our computational research, which constitutes a substantial proportion of our work, will continue as normal off site.  

Our Clinical Trials and Statistics Unit has also issued a statement regarding the effect of COVID-19 on our clinical trials.

Interviews

Dates provided for interviews (for career vacancies as well as for PhD studentships) are liable to change and interviews should now take place using video conferencing solutions where possible. We will notify applicants of any changes as soon as we can.

Travel advice

The Mayor of London has advised the public to not use public transport unless 'genuinely essential'. Many London Underground stations have been shut to reduce the spread of coronavirus. Please check the Transport for London website before travelling in London.

Disruption to sporting events

Some of our fundraising events have been disrupted. If you were due to take part in the following events on behalf of the ICR, please contact [email protected]icr.ac.uk. We also suggest that people visit the official websites for any events for the latest updates.